期刊文献+

分子影像技术在多药耐药监测中的研究进展

The progress of molecular imaging in multidrug resistance
原文传递
导出
摘要 肿瘤的多药耐药(MDR)是导致癌症复发和转移的重要因素.ATP结合盒转运蛋白(ABC转运蛋白)在人体广泛存在,并且ABC转运蛋白的过度表达是导致肿瘤细胞产生MDR的主要原因之一.利用分子影像技术对MDR肿瘤进行早期监测,有利于临床医师制定有效的治疗方案,并在一定程度上能改善肿瘤患者的预后.笔者就分子影像技术在监测MDR方面的研究进展进行简要综述. Tumor multidrug resistance(MDR)is an important factor that leads to cancer recurrence and metastasis.ATP-binding cassette transporters are widely present in humans,and their overexpression mainly induces MDR in tumor cells.Molecular imaging for the early monitoring of MDR tumors is helpful for clinicians to formulate effective treatment plans and improve tumor prognosis to a certain extent.This study briefly reviews the research progress on molecular imaging for MDR monitoring.
作者 叶敏 夏晓天 兰晓莉 张永学 Ye Min;Xia Xiaotian;Lan Xiaoli;Zhang Yongxue(Department of Nuclear Medicine,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Hubei Key Laboratory of Molecular Imaging)
出处 《国际放射医学核医学杂志》 2020年第3期174-181,共8页 International Journal of Radiation Medicine and Nuclear Medicine
基金 国家自然科学基金(81771863、81630049、81801737)。
关键词 抗药性 多药 单光子发射计算机体层摄影术 正电子发射断层显像术 ATP结合盒转运体 分子影像技术 Drug resistance multidrug Single photon emission computed tomography Positron emission tomography ATP-binding cassette transporter Molecular imaging technology
  • 相关文献

参考文献2

二级参考文献33

  • 1林开文,刘保平,程兵.乳腺癌^(99)Tc^m-MIBI显像与P-gp、MRP表达的关系[J].中华核医学杂志,2005,25(5):288-290. 被引量:6
  • 2崔树德,刘真真,刘慧,李连方,杨辉,李文亮.甲氧基乙丁基异腈亲肿瘤显像与乳腺癌多药耐药类蛋白关系的研究[J].中华肿瘤杂志,2005,27(10):606-608. 被引量:9
  • 3张雪梅,刘志军,杨秀蓉.^(99m)Tc-MIBI显像可预测乳腺癌新辅助化疗的反应性[J].生物医学工程与临床,2006,10(5):290-292. 被引量:5
  • 4Kolesnikov-Gauthier H, Vanlemmens L, Baranzelli MC, et al. Pre- dictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course[J]. Breast Cancer Res Treat, 2012, 131(2): 517-525.
  • 5Sun Y, Wei W, Yang HW, et al. Clinical usefulness of breast-spe- cific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis[J]. EurJ Nucl Med Mol Imaging, 2013, 40(3) : 450-463.
  • 6Sergieva SB, Timcheva KV, Hadjiolov ND. 99Tc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients[J]. J BUON, 2006, 11 ( 1 ) : 61-68.
  • 7Mankoff DA, Dunnwald LK, Gralow JR, et al. Monitoring the re- sponse of patients with locally advanced breast carcinoma to neoad- juvant chemotherapy using[Technetium 99m]-sestamibi scintimam- mography[J]. Cancer, 1999, 85 (11 ) : 2410-2423.
  • 8Spanu A, Farris A, Chessa F, et al. Planar scintimammography and SPECT in neoadjuvant chemo or hormonotherapy response evalua- tion in locally advanced primary breast cancer[J]. Int J Oncol, 2008, 32(6) : 1275-1283.
  • 9Fuster D, Mufioz M, Pavia J, et al. Quantified 99mTc-MIBI scintigra- phy for predicting chemotherapy response in breast cancer pa- tients: factors that influence the level of 99Tc-MIBI uptake [J]. Nucl Med Commun, 2002, 23(1) : 31-38.
  • 10Novikov SN, Kanaev SV, Petr KV, et al. Technetium-99m methoxy- isobutylisonitrile scintimammography for monitoring and early pre- diction of breast cancer response to neoadjuvant chemotherapy[J]. Nuel Med Commun, 2015, 36(8) : 795-801.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部